- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
SNY
SNY Stock Alert: Why 1 Analyst Says Zantac Ruling Is ‘Best-Case Scenario’ for Drugmakers
Sanofi (SNY) stock is in the news as one analyst believes the latest court ruling is the "best-case scenario" for the drugmaker.
GSK, PFE, SNY Stocks Fall on Zantac Litigation
You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning! We're starting off Thursday with an overview of the biggest pre-market stock movers that traders need to watch!
KDMN Stock: 6 Things to Know About Biopharma Kadmon Holdings as Shares Skyrocket
Kadmon Holdings (KDMN) stock is rising higher on Wednesday following news of a deal with Sanofi (SNY) that comes to $1.9 billion.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week right with a collection of the biggest pre-market stock movers for Monday that investors need to know about.
GlaxoSmithKline and Sanofi Stock Rally on EU Vaccine Deal
GlaxoSmithKline and Sanofi stock are rallying in early trading on Friday thanks to news they would supply the EU 300 million vaccine doses.
Once Slow, Stable Sanofi Stock is Now Pharma’s Most-Talked About Name
SNY stock is no longer a sleepy passive investment. Under a new CEO, Sanofi is less reliant on diabetes and heart drugs and looking to buy pre-market cancer blockbusters.